The altered lung microbiome dynamics in patients with moderate and severe COPD compared to the healthy group in the Indian population
暂无分享,去创建一个
[1] Wei Li,et al. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study , 2022, Respiratory Research.
[2] L. Segal,et al. The dynamic lung microbiome in health and disease , 2022, Nature Reviews Microbiology.
[3] G. Collins,et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019 , 2022, BMJ.
[4] Sarah E Clark,et al. Airway Prevotella promote TLR2-dependent neutrophil activation and rapid clearance of Streptococcus pneumoniae from the lung , 2022, Nature Communications.
[5] Jianchao Wei,et al. Targeting the Pulmonary Microbiota to Fight against Respiratory Diseases , 2022, Cells.
[6] Hongbing Zhang,et al. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices , 2022, Journal of translational medicine.
[7] P. Parás-Bravo,et al. Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review , 2021, Health Economics Review.
[8] S. Heath,et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. , 2021, The Lancet. Microbe.
[9] Chi-Ching Lee,et al. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state , 2021, Journal of Translational Medicine.
[10] A. Ismaila,et al. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review , 2020, International journal of chronic obstructive pulmonary disease.
[11] James R. Brown,et al. Airway host-microbiome interactions in chronic obstructive pulmonary disease , 2019, Respiratory Research.
[12] Highlights from this issue , 2018, Thorax.
[13] C. Reilly,et al. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease , 2017, Microbiome.
[14] K. Hao,et al. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease , 2017, Chinese medical journal.
[15] James R. Brown,et al. Lung microbiome dynamics in COPD exacerbations , 2016, European Respiratory Journal.
[16] T. Kiljander,et al. Annual costs of chronic obstructive pulmonary disease in Finland during 1996–2006 and a prediction model for 2007–2030 , 2015, npj Primary Care Respiratory Medicine.
[17] V. Pérez-Brocal,et al. Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease , 2014, Journal of Clinical Microbiology.
[18] Gert Folkerts,et al. Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma , 2014, Respiratory Research.
[19] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[20] Joel Cooper,et al. The lung tissue microbiome in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[21] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[22] Martin Hartmann,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[23] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[24] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.